Bloomage Biotechnology Corp Ltd Financial Flexibility Index
Bloomage Biotechnology Corp Ltd financial flexibility index. Bloomage Biotechnology Corp Ltd (688363) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥166.24 Million (operating CF CN¥93.75 Million minus capex CN¥72.49 Million) represents 0% of total liabilities (CN¥1.38 Billion). Explore 688363 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Bloomage Biotechnology Corp Ltd (2012–2025)
Financial flexibility index of Bloomage Biotechnology Corp Ltd from 2012 to 2025. Historical Financial Flexibility Index trend for Bloomage Biotechnology Corp Ltd across 14 annual periods. Check Bloomage Biotechnology Corp Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Bloomage Biotechnology Corp Ltd Financial Flexibility Index by Year (2012–2025)
Bloomage Biotechnology Corp Ltd financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Bloomage Biotechnology Corp Ltd. For the full cash flow conversion analysis, see 688363 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | CN¥953.13 Million | CN¥627.45 Million | CN¥1.58 Billion | ▼ -14.6% |
| 2024 | 0.71x | CN¥1.29 Billion | CN¥564.51 Million | CN¥1.82 Billion | ▼ -39.2% |
| 2023 | 1.16x | CN¥1.73 Billion | CN¥699.65 Million | CN¥1.49 Billion | ▲ +74.7% |
| 2022 | 0.67x | CN¥1.33 Billion | CN¥635.19 Million | CN¥2.00 Billion | ▼ -41.8% |
| 2021 | 1.14x | CN¥2.06 Billion | CN¥1.28 Billion | CN¥1.80 Billion | ▼ -51.5% |
| 2020 | 2.36x | CN¥1.47 Billion | CN¥705.12 Million | CN¥622.68 Million | ▲ +22.1% |
| 2019 | 1.93x | CN¥815.12 Million | CN¥364.89 Million | CN¥422.11 Million | ▲ +11.8% |
| 2018 | 1.73x | CN¥610.72 Million | CN¥442.30 Million | CN¥353.56 Million | ▲ +8.8% |
| 2017 | 1.59x | CN¥389.42 Million | CN¥343.42 Million | CN¥245.35 Million | ▲ +157.0% |
| 2016 | 0.62x | CN¥261.59 Million | CN¥241.68 Million | CN¥423.53 Million | ▲ +50.8% |
| 2015 | 0.41x | CN¥412.64 Million | CN¥145.67 Million | CN¥1.01 Billion | ▼ -65.9% |
| 2014 | 1.20x | CN¥255.92 Million | CN¥137.47 Million | CN¥212.94 Million | ▼ -9.0% |
| 2013 | 1.32x | CN¥269.45 Million | CN¥155.33 Million | CN¥203.96 Million | ▼ -1.2% |
| 2012 | 1.34x | CN¥130.15 Million | CN¥83.62 Million | CN¥97.29 Million | — |